TY - JOUR
T1 - Return to Work and Associated Costs after Treatment for Dupuytren's Disease
AU - Blake, Shacara N.
AU - Poelstra, Ralph
AU - Andrinopoulou, Eleni Rosalina
AU - Obdeijn, Miryam C.
AU - Van De Oest, Mark J.W.
AU - Feitz, Reinier
AU - Burdorf, Alex
AU - Selles, Ruud W.
N1 - Publisher Copyright:
© 2021 Lippincott Williams and Wilkins. All rights reserved.
PY - 2021/9
Y1 - 2021/9
N2 - Background: Return to work is potentially an important factor in assessing the success of treatment. However, little is known about the return to work after treatment for Dupuytren's contracture. Therefore, the primary aim of this study was to assess return to work after limited fasciectomy and percutaneous needle fasciotomy. Methods: Patients who underwent either a limited fasciectomy or percutaneous needle fasciotomy were invited to complete a return-To-work questionnaire at 6 weeks, 3 months, 6 months, and 12 months postoperatively. Median time to return to work was assessed using inverted Kaplan-Meier curves, and hazard ratios were calculated with Cox regression models. Finally, a cost analysis was carried out using the human capital method to determine indirect costs associated with loss of productivity. Results: The authors included 2698 patients in the study, of which 53 percent were employed at intake and included in the follow-up. After 1 year of follow-up, 90 percent of the patients had returned to work. Median time to return to work was 2 weeks after limited fasciectomy and within days after percutaneous needle fasciotomy. Furthermore, physically strenuous work, female sex, and higher age were associated with a longer time to return to work. Lost productivity per patient was estimated at €2614.43. Conclusions: The majority of patients returned to work after treatment for Dupuytren's disease. Return to work is much faster after percutaneous needle fasciotomy compared to limited fasciectomy. These findings can be used for more evidence-based preoperative counseling with patients with Dupuytren's disease.
AB - Background: Return to work is potentially an important factor in assessing the success of treatment. However, little is known about the return to work after treatment for Dupuytren's contracture. Therefore, the primary aim of this study was to assess return to work after limited fasciectomy and percutaneous needle fasciotomy. Methods: Patients who underwent either a limited fasciectomy or percutaneous needle fasciotomy were invited to complete a return-To-work questionnaire at 6 weeks, 3 months, 6 months, and 12 months postoperatively. Median time to return to work was assessed using inverted Kaplan-Meier curves, and hazard ratios were calculated with Cox regression models. Finally, a cost analysis was carried out using the human capital method to determine indirect costs associated with loss of productivity. Results: The authors included 2698 patients in the study, of which 53 percent were employed at intake and included in the follow-up. After 1 year of follow-up, 90 percent of the patients had returned to work. Median time to return to work was 2 weeks after limited fasciectomy and within days after percutaneous needle fasciotomy. Furthermore, physically strenuous work, female sex, and higher age were associated with a longer time to return to work. Lost productivity per patient was estimated at €2614.43. Conclusions: The majority of patients returned to work after treatment for Dupuytren's disease. Return to work is much faster after percutaneous needle fasciotomy compared to limited fasciectomy. These findings can be used for more evidence-based preoperative counseling with patients with Dupuytren's disease.
UR - http://www.scopus.com/inward/record.url?scp=85104085790&partnerID=8YFLogxK
UR - https://www.researchgate.net/publication/353415124_Return_to_Work_and_Associated_Costs_after_Treatment_for_Dupuytren%27s_Disease
U2 - 10.1097/PRS.0000000000008224
DO - 10.1097/PRS.0000000000008224
M3 - Article
C2 - 34292887
AN - SCOPUS:85104085790
SN - 0032-1052
VL - 148
SP - 580
EP - 590
JO - Plastic and Reconstructive Surgery
JF - Plastic and Reconstructive Surgery
IS - 3
ER -
